Preferences for Advanced Parkinson’s Disease Treatments from People with Parkinson’s and Care Partners: Insights from a Discrete-choice Experiment (P4-5.023)
Josefa Domingos(Escola Superior de Saúde Egas Moniz), Marieke Heisen, Megha Shah(Emory University), К. Ray Chaudhuri(NIHR Maudsley Dementia Biomedical Research Unit), Angelo Antonini(University of Padua), Irene A. Malaty(University of Florida), Hannah Penton, Juan Carlos Parra(AbbVie (United States)), Connie Yan(AbbVie (United States)), Pablo Prieto, Rajesh Pahwa(University of Kansas Medical Center), Pavnit Kukreja(AbbVie (United States)), Elaheh Shirneshan(AbbVie (United States)), Francesco De Renzis(Parkinson's UK), Marco Boeri(Queen's University Belfast)
Cited by 1
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The STARTEC Decision Support Tool for Better Tradeoffs between Food Safety, Quality, Nutrition, and Costs in Production of Advanced Ready-to-Eat Foods
|BioMed Research International|2017|1.2k
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
|Movement Disorders|2006|1.1k
Prevalence of and Factors Associated With Nurse Burnout in the US
|JAMA Network Open|2021|661
<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease
|European Journal of Neurology|2012|490